Disc Medicine, Inc. (NASDAQ:IRON)
| Market Cap | 2.49B-0.2% |
| Revenue (ttm) | 0 |
| Net Income | -245.89M-69.1% |
| EPS | -6.60-47.7% |
| Shares Out | 38.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 480,547 |
| Open | 64.83 |
| Previous Close | 65.24 |
| Day's Range | 63.96 - 66.25 |
| 52-Week Range | 40.00 - 99.50 |
| Beta | 2.05 |
| Analysts | Buy |
| Price Target | 106.00(+63.28%) |
| Earnings Date | Nov 5, 2026 |
Disc Medicine, Inc. has a live Insider Score.
Scored on 0 qualifying trades from 0 insiders in the last 90 days.
About IRON
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$IRON stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in IRON holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by IRON's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
IRON Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New IRON patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to IRON from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in IRON
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $76.65M |
| XBIState Street SPDR S&P Biotech ETF | $49.14M |
| IWMiShares Russell 2000 ETF | $48.02M |
| VXFVanguard Extended Market ETF | $29.26M |
| IWOiShares Russell 2000 Growth ETF | $17.74M |
| IBBiShares Biotechnology ETF | $14.13M |
Estimated from each fund’s disclosed top holdings × AUM
IRON Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from IRON’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score